Loading...
Keywords
Last Name
Institution

Hugo Escobar

Concepts (114)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
3
2021
18
0.820
Why?
Lung Diseases
3
2017
23
0.640
Why?
Aminophenols
2
2018
2
0.450
Why?
Quinolones
2
2018
2
0.450
Why?
Benzodioxoles
2
2018
2
0.450
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
2
2018
3
0.450
Why?
Pseudomonas Infections
1
2021
7
0.390
Why?
Bronchopulmonary Dysplasia
3
2018
39
0.360
Why?
Pyrrolidines
1
2018
1
0.320
Why?
Chloride Channel Agonists
1
2018
1
0.320
Why?
Pyrazoles
1
2018
3
0.320
Why?
Indoles
1
2018
3
0.320
Why?
Nitric Oxide
2
2018
6
0.300
Why?
Respiratory Insufficiency
2
2018
13
0.300
Why?
Humans
11
2023
6915
0.230
Why?
Respiratory Function Tests
3
2018
16
0.220
Why?
Intensive Care Units, Pediatric
1
2023
11
0.220
Why?
Hospitalization
2
2023
217
0.210
Why?
Forced Expiratory Volume
3
2021
10
0.210
Why?
Lung
2
2018
65
0.180
Why?
Infant, Premature, Diseases
2
2018
22
0.180
Why?
Infant, Newborn
6
2023
825
0.180
Why?
Male
8
2018
3383
0.180
Why?
Administration, Inhalation
3
2021
19
0.170
Why?
Exercise Tolerance
1
2018
8
0.160
Why?
Bronchodilator Agents
1
2018
11
0.160
Why?
Bronchitis
1
2018
1
0.160
Why?
Microsurgery
1
2018
1
0.160
Why?
Mycobacterium avium Complex
1
2018
1
0.160
Why?
Laser Therapy
1
2018
4
0.160
Why?
Mycobacterium avium-intracellulare Infection
1
2018
2
0.160
Why?
Bronchoalveolar Lavage Fluid
1
2018
12
0.160
Why?
Antitubercular Agents
1
2018
7
0.160
Why?
Female
7
2018
3563
0.150
Why?
Intermittent Positive-Pressure Ventilation
1
2017
1
0.150
Why?
Interactive Ventilatory Support
1
2017
1
0.150
Why?
Prospective Studies
3
2021
532
0.150
Why?
Energy Metabolism
1
2017
28
0.150
Why?
Fluorescent Dyes
1
2017
7
0.140
Why?
Exhalation
1
2017
1
0.140
Why?
Flow Cytometry
1
2017
30
0.140
Why?
Antibodies, Monoclonal
1
2017
23
0.140
Why?
Tracheostomy
1
2017
14
0.140
Why?
Aminopyridines
1
2015
2
0.130
Why?
Steroids
1
2013
16
0.110
Why?
Severity of Illness Index
3
2023
153
0.110
Why?
Infant, Extremely Premature
1
2013
12
0.110
Why?
Virus Diseases
1
2013
16
0.110
Why?
Bacterial Infections
1
2013
27
0.110
Why?
Double-Blind Method
2
2018
45
0.110
Why?
Infant
4
2023
1464
0.110
Why?
Adolescent
3
2023
2235
0.100
Why?
Respiratory Tract Infections
1
2013
85
0.100
Why?
Mutation
2
2018
213
0.100
Why?
Plethysmography
1
2011
5
0.100
Why?
Oscillometry
1
2011
2
0.100
Why?
Spirometry
1
2011
7
0.100
Why?
Respiration
1
2011
5
0.100
Why?
Tobramycin
1
2021
3
0.100
Why?
Azithromycin
1
2021
5
0.100
Why?
Infant, Premature
3
2018
84
0.100
Why?
Pseudomonas aeruginosa
1
2021
7
0.100
Why?
Child, Preschool
2
2018
1600
0.100
Why?
Young Adult
2
2018
657
0.090
Why?
Acids
1
2010
1
0.090
Why?
Pepsin A
1
2010
1
0.090
Why?
Mucin-5B
1
2010
1
0.090
Why?
Ear, Middle
1
2010
2
0.090
Why?
Gene Expression
1
2010
65
0.080
Why?
Adult
2
2018
1187
0.080
Why?
Sweat
1
2018
1
0.080
Why?
Chlorides
1
2018
4
0.080
Why?
Drug Combinations
1
2018
20
0.080
Why?
Anti-Bacterial Agents
1
2021
251
0.080
Why?
Cells, Cultured
1
2018
81
0.080
Why?
Alleles
1
2018
215
0.070
Why?
Genotype
1
2018
410
0.070
Why?
Reproducibility of Results
2
2017
201
0.070
Why?
Child
3
2023
3393
0.070
Why?
Follow-Up Studies
2
2018
302
0.060
Why?
Retrospective Studies
2
2023
1300
0.060
Why?
Hospital Mortality
1
2023
21
0.050
Why?
Mice
2
2017
345
0.050
Why?
Animals
2
2017
657
0.050
Why?
Bronchoscopy
1
2018
7
0.040
Why?
Diagnosis, Differential
1
2018
77
0.040
Why?
Respiratory Rate
1
2017
3
0.040
Why?
Oxygen
1
2017
14
0.040
Why?
Tomography, X-Ray Computed
1
2018
117
0.040
Why?
Cross-Over Studies
1
2017
36
0.040
Why?
Gestational Age
1
2017
62
0.040
Why?
Intensive Care Units, Neonatal
1
2017
35
0.040
Why?
Missouri
1
2017
80
0.040
Why?
Protein Stability
1
2017
1
0.040
Why?
Breath Tests
1
2017
10
0.040
Why?
Cross-Sectional Studies
1
2017
339
0.030
Why?
Drug Therapy, Combination
1
2015
35
0.030
Why?
Homozygote
1
2015
20
0.030
Why?
Diuretics
1
2013
4
0.030
Why?
Oxygen Inhalation Therapy
1
2013
3
0.030
Why?
Infant, Very Low Birth Weight
1
2013
10
0.030
Why?
ROC Curve
1
2013
22
0.030
Why?
Logistic Models
1
2013
85
0.030
Why?
Middle Aged
1
2015
614
0.030
Why?
Prognosis
1
2013
212
0.030
Why?
Cohort Studies
1
2013
288
0.030
Why?
Risk Factors
1
2013
485
0.020
Why?
Hydrogen-Ion Concentration
1
2010
19
0.020
Why?
In Vitro Techniques
1
2010
22
0.020
Why?
Cell Survival
1
2010
19
0.020
Why?
Up-Regulation
1
2010
25
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
67
0.020
Why?
Cell Line
1
2010
81
0.020
Why?
RNA, Messenger
1
2010
112
0.020
Why?
Escobar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_